Lung Kee (Bermuda) Holdings Limited (0255) Stock Statistics & Valuation Metrics

Lung Kee (Bermuda) Holdings Limited has a market cap or net worth of HK$922.25M. The enterprise value is HK$339.21M.

Lung Kee (Bermuda) Holdings Limited has 631,677,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lung Kee (Bermuda) Holdings Limited’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -1.04%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Lung Kee (Bermuda) Holdings Limited had revenue of 1.55B and earned -13.67M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 226.34M and capital expenditures -35.51M, giving a free cash flow of 190.82M billion.

Lung Kee (Bermuda) Holdings Limited pays an annual dividend of HK$0.06, resulting in a dividend yield of 6.09%

Lung Kee (Bermuda) Holdings Limited upcoming earnings date is Aug 22, 2025, TBA (Not Confirmed).

Lung Kee (Bermuda) Holdings Limited as a current ratio of 5.77, with Debt / Equity ratio of 0.47%

In the past 12 months, Lung Kee (Bermuda) Holdings Limited has paid -5.68M in taxes.

Lung Kee (Bermuda) Holdings Limited EV to EBITDA ratio is 0.92, with an EV/FCF ratio of 0.72.

Lung Kee (Bermuda) Holdings Limited has HK$546.65M in cash and marketable securities with HK$7.83M in debt, giving a net cash position of -HK$538.82M billion.

Gross margin is 57.87%, with operating margin of -1.67%, and net profit margin of -0.88%.

The average price target for Lung Kee (Bermuda) Holdings Limited is HK$1.50, which is 11.43% higher than the current price. The consensus rating is Hold